WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (63)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benmansour, S.
Right arrow Articles by Frazer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benmansour, S.
Right arrow Articles by Frazer, A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2002, 22(15):6766-6772

Serotonin Clearance In Vivo Is Altered to a Greater Extent by Antidepressant-Induced Downregulation of the Serotonin Transporter than by Acute Blockade of this Transporter

Saloua Benmansour1, William A. Owens1, Marco Cecchi1, David A. Morilak1, and Alan Frazer1, 2

1 Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 2 South Texas Veterans Health Care System, San Antonio, Texas 78284

Serotonin uptake, mediated by the serotonin transporter (SERT), is blocked acutely by antidepressants such as the selective serotonin reuptake inhibitors (SSRIs), but such blockade does not correlate temporally with the onset of therapeutic improvement. Treatment with SSRIs for 21 d induced downregulation of the SERT (Benmansour et al., 1999). The time course of SERT downregulation as well as the time course for its recovery after cessation of treatment with the SSRI sertraline were investigated using tritiated cyanoimipramine to measure SERT binding sites. To determine if there was a temporal correlation between the time when sertraline induced downregulation of the SERT and when marked alteration in SERT function occurred, clearance of locally applied 5-HT into the CA3 region of hippocampus was achieved using in vivo electrochemistry. After 4 or 10 d treatment with sertraline, SERT binding sites decreased very little (15-30%), and the chronoamperometric signals for serotonin in sertraline-treated rats were comparable with ones obtained in control animals. By contrast, after 15 d of treatment, when SERT binding sites were markedly reduced by 80%, there was robust decrease in the clearance of 5-HT. Moreover, the functional consequences of SERT downregulation as measured by chronoamperometry were significantly greater than those seen after acute blockade of the SERT by SSRIs. SERT binding sites decreases are not a consequence of reduced SERT gene expression, as revealed by in situ hybridization measurements. SSRI-induced downregulation of the SERT may be a key component for the clinical response to SSRIs.

Key words: serotonin transporter; antidepressant; sertraline; chronoamperometry; downregulation; mRNA


Copyright © 2002 Society for Neuroscience  0270-6474/02/22156766-07$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
K. Kobayashi, Y. Ikeda, E. Haneda, and H. Suzuki
Chronic Fluoxetine Bidirectionally Modulates Potentiating Effects of Serotonin on the Hippocampal Mossy Fiber Synaptic Transmission
J. Neurosci., June 11, 2008; 28(24): 6272 - 6280.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. Lau, S. Horschitz, S. Berger, D. Bartsch, and P. Schloss
Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons
FASEB J, June 1, 2008; 22(6): 1702 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. M. Sanders, C. W. Wilkinson, G. J. Taborsky Jr., S. Al-Noori, W. Daumen, A. Zavosh, and D. P. Figlewicz
The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E853 - E860.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. C. Taylor, A. Li, A. Green, H. C. Kinney, and E. E. Nattie
Chronic fluoxetine microdialysis into the medullary raphe nuclei of the rat, but not systemic administration, increases the ventilatory response to CO2
J Appl Physiol, November 1, 2004; 97(5): 1763 - 1773.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2010 by Society for Neuroscience ONLINE ISSN: 1529-2401
-